These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
172 related items for PubMed ID: 6897533
1. Treatment of Graves' ophthalmopathy by steroid therapy, orbital radiation therapy, plasmapheresis and thyroxine replacement. Yamamoto K, Saito K, Takai T, Yoshida S. Endocrinol Jpn; 1982 Aug; 29(4):495-501. PubMed ID: 6897533 [Abstract] [Full Text] [Related]
2. Diagnosis of exophthalmos using orbital ultrasonography and treatment of malignant exophthalmos with steroid therapy, orbital radiation therapy, and plasmapheresis. Yamamoto K, Saito K, Takai T, Yoshida S. Prog Clin Biol Res; 1983 Aug; 116():189-205. PubMed ID: 6134291 [Abstract] [Full Text] [Related]
4. A prospective, randomized, double-blind, placebo-controlled study of orbital radiotherapy for Graves' ophthalmopathy. Gorman CA, Garrity JA, Fatourechi V, Bahn RS, Petersen IA, Stafford SL, Earle JD, Forbes GS, Kline RW, Bergstralh EJ, Offord KP, Rademacher DM, Stanley NM, Bartley GB. Ophthalmology; 2001 Sep; 108(9):1523-34. PubMed ID: 11535445 [Abstract] [Full Text] [Related]
5. Prognostic factors in the radiotherapy of Graves' ophthalmopathy. Petersen IA, Kriss JP, McDougall IR, Donaldson SS. Int J Radiat Oncol Biol Phys; 1990 Aug; 19(2):259-64. PubMed ID: 2118493 [Abstract] [Full Text] [Related]
6. Orbital cobalt irradiation combined with systemic corticosteroids for Graves' ophthalmopathy: comparison with systemic corticosteroids alone. Bartalena L, Marcocci C, Chiovato L, Laddaga M, Lepri G, Andreani D, Cavallacci G, Baschieri L, Pinchera A. J Clin Endocrinol Metab; 1983 Jun; 56(6):1139-44. PubMed ID: 6341388 [Abstract] [Full Text] [Related]
7. Successful treatment of hypothyroid Graves' disease with a combination of levothyroxine replacement, intravenous high-dose steroid and irradiation to the orbit. Koshiyama H, Mori S, Fujiwara K, Hayakawa K, Koh T. Intern Med; 1993 May; 32(5):421-3. PubMed ID: 8400507 [Abstract] [Full Text] [Related]
8. The aftermath of orbital radiotherapy for graves' ophthalmopathy. Gorman CA, Garrity JA, Fatourechi V, Bahn RS, Petersen IA, Stafford SL, Earle JD, Forbes GS, Kline RW, Buettner H, Robertson DM, Bergstralh EJ, Offord KP, Rademacher DM, Stanley NM, Bartley GB. Ophthalmology; 2002 Nov; 109(11):2100-7. PubMed ID: 12414422 [Abstract] [Full Text] [Related]
9. A Prospective, Randomized, Double-blind, Placebo-controlled Study of Orbital Radiotherapy for Graves' Ophthalmopathy. Gorman CA, Garrity JA, Fatourechi V, Bahn RS, Petersen IA, Stafford SL, Earle JD, Forbes GS, Kline RW, Bergstralh EJ, Offord KP, Rademacher DM, Stanley NM, Bartley GB. Ophthalmology; 2020 Apr; 127(4S):S160-S171. PubMed ID: 32200817 [Abstract] [Full Text] [Related]
10. [Use of plasmapheresis in a case of Graves' disease with malignant ophthalmopathy (author's transl)]. Glinoer D, Gaham N, Sand G, Libert J, Grivegnee A, Badjou R, Ermans AM. Ann Endocrinol (Paris); 1981 Dec; 42(6):545-6. PubMed ID: 6896620 [Abstract] [Full Text] [Related]
12. Predictors of response to transantral orbital decompression in severe Graves' ophthalmopathy. Fatourechi V, Bergstralh EJ, Garrity JA, Bartley GB, Beatty CW, Offord KP, Gorman CA. Mayo Clin Proc; 1994 Sep; 69(9):841-8. PubMed ID: 8065185 [Abstract] [Full Text] [Related]
13. Orbital radiotherapy combined with high dose systemic glucocorticoids for Graves' ophthalmopathy is more effective than radiotherapy alone: results of a prospective randomized study. Marcocci C, Bartalena L, Bogazzi F, Bruno-Bossio G, Lepri A, Pinchera A. J Endocrinol Invest; 1991 Nov; 14(10):853-60. PubMed ID: 1802923 [Abstract] [Full Text] [Related]
14. Beneficial effects of intensive plasma exchange followed by immunosuppressive therapy in severe Graves' ophthalmopathy. Glinoer D, Etienne-Decerf J, Schrooyen M, Sand G, Hoyoux P, Mahieu P, Winand R. Acta Endocrinol (Copenh); 1986 Jan; 111(1):30-8. PubMed ID: 2868602 [Abstract] [Full Text] [Related]
15. Beneficial effects of intensive plasma exchange followed by immunosuppressive therapy in severe Graves' ophthalmopathy. Glinoer D, Etienne-Decerf J, Schrooyen M, Sand G, Hoyoux P, Mahieu P, Winand R. Metab Pediatr Syst Ophthalmol (1985); 1988 Jan; 11(3):133-40. PubMed ID: 3205168 [Abstract] [Full Text] [Related]
16. An evaluation of supervoltage orbital irradiation for Graves' ophthalmopathy. Teng CS, Crombie AL, Hall R, Ross WM. Clin Endocrinol (Oxf); 1980 Dec; 13(6):545-51. PubMed ID: 6784979 [Abstract] [Full Text] [Related]
17. Plasma exchange therapy for severe Graves' ophthalmopathy. Glinoer D, Schrooyen M. Horm Res; 1987 Dec; 26(1-4):184-9. PubMed ID: 3596467 [Abstract] [Full Text] [Related]
18. [Effects of external orbital radiotherapy on the oculomotor muscle in Graves disease]. Maalouf T, Angioi-Duprez K, Beckendorff V, Malet T, George JL. J Fr Ophtalmol; 1996 Dec; 19(12):748-54. PubMed ID: 9033899 [Abstract] [Full Text] [Related]
19. Clinical evaluation of radiotherapy for Graves' ophthalmopathy. Konishi J, Iida Y, Kasagi K, Misaki T, Arai K, Endo K, Amemiya T, Abe M, Torizuka K. Endocrinol Jpn; 1986 Oct; 33(5):637-44. PubMed ID: 3830071 [Abstract] [Full Text] [Related]
20. Effect of high-dose intravenous steroid pulse therapy followed by 3-month oral steroid therapy for Graves' ophthalmopathy. Ohtsuka K, Sato A, Kawaguchi S, Hashimoto M, Suzuki Y. Jpn J Ophthalmol; 2002 Oct; 46(5):563-7. PubMed ID: 12457917 [Abstract] [Full Text] [Related] Page: [Next] [New Search]